Paper36009010
Design, Synthesis and Activity of New N1-Alkyl Tryptophan Functionalized Dendrimeric Peptides against Glioblastoma.
Sowińska M and 4 others. Biomolecules, 2022. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Design, Synthesis and Activity of New N1-Alkyl Tryptophan Functionalized Dendrimeric Peptides against Glioblastoma. Papers, record 36009010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36009010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Design, Synthesis and Activity of New N1-Alkyl Tryptophan Functionalized Dendrimeric Peptides against Glioblastoma.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dendrimers | Major topic |
| Glioblastoma | Major topic |
| Antioxidants | |
| Cell Line, Tumor | |
| Humans | |
| Peptides | |
| Reactive Oxygen Species | |
| Tryptophan |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26748400 | Effects of resveratrol and methoxyamine on the radiosensitivity of iododeoxyuridine in U87MG glioblastoma cell line. | Exp Biol Med (Maywood) | 2016 | https://conductscience.org/library/papers/26748400 | PubMed |
| 2 | 16227395 | Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. | Mol Cancer Ther | 2005 | https://conductscience.org/library/papers/16227395 | PubMed |
| 3 | 34924003 | Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1. | Cell Biosci | 2021 | https://conductscience.org/library/papers/34924003 | PubMed |
| 4 | 32326311 | The Role of Branch Cell Symmetry and Other Critical Nanoscale Design Parameters in the Determination of Dendrimer Encapsulation Properties. | Biomolecules | 2020 | https://conductscience.org/library/papers/32326311 | PubMed |
| 5 | 31518706 | Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review. | Acta Biomater | 2020 | https://conductscience.org/library/papers/31518706 | PubMed |
| 6 | 27832093 | Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or Astrocytes. | PLoS One | 2016 | https://conductscience.org/library/papers/27832093 | PubMed |
| 7 | 29031179 | Carbosilane metallodendrimers based on copper (II) complexes: Synthesis, EPR characterization and anticancer activity. | J Inorg Biochem | 2017 | https://conductscience.org/library/papers/29031179 | PubMed |
| 8 | 25345694 | 1,n-Hydrogen-atom transfer (HAT) reactions in which n≠5: an updated inventory. | Chemistry | 2014 | https://conductscience.org/library/papers/25345694 | PubMed |
| 9 | 16166279 | Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. | Cancer Res | 2005 | https://conductscience.org/library/papers/16166279 | PubMed |
| 10 | 15382062 | Role of reactive oxygen species in the induction of apoptosis by alpha-tocopheryl succinate. | Int J Cancer | 2004 | https://conductscience.org/library/papers/15382062 | PubMed |
| 11 | 28965321 | Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action. | Mol Neurobiol | 2018 | https://conductscience.org/library/papers/28965321 | PubMed |
| 12 | 24088539 | Antioxidant activity of selected phenols estimated by ABTS and FRAP methods. | Postepy Hig Med Dosw (Online) | 2013 | https://conductscience.org/library/papers/24088539 | PubMed |
| 13 | 31556597 | Designer Peptide and Protein Dendrimers: A Cross-Sectional Analysis. | Chem Rev | 2019 | https://conductscience.org/library/papers/31556597 | PubMed |
| 14 | 30235928 | Bioinspired Amphiphilic Peptide Dendrimers as Specific and Effective Compounds against Drug Resistant Clinical Isolates of E. coli. | Bioconjug Chem | 2018 | https://conductscience.org/library/papers/30235928 | PubMed |
| 15 | 32290213 | Glioblastoma: Pathogenesis and Current Status of Chemotherapy and Other Novel Treatments. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32290213 | PubMed |
| 16 | 21945565 | Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs. | Chem Phys Lipids | 2011 | https://conductscience.org/library/papers/21945565 | PubMed |
| 17 | 20116448 | Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. | Drug Discov Today | 2010 | https://conductscience.org/library/papers/20116448 | PubMed |
| 18 | 30581608 | Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review. | J Adv Res | 2019 | https://conductscience.org/library/papers/30581608 | PubMed |
| 19 | 8660627 | The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. | Anal Biochem | 1996 | https://conductscience.org/library/papers/8660627 | PubMed |
| 20 | 24995512 | Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications. | J Intern Med | 2014 | https://conductscience.org/library/papers/24995512 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42489969 | NAD⁺ biology and supplementation: From mechanisms to clinical perspectives. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42489969 | PubMed |
| 37258638 | The first evidence of biological activity for free Hypusine, an enigmatic amino acid discovered in the '70s. | Amino Acids | 2023 | https://conductscience.org/library/papers/37258638 | PubMed |
| 37046777 | Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM). | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37046777 | PubMed |
| 37006997 | Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37006997 | PubMed |
| 36979448 | Screening of EWI-2-Derived Peptides for Targeting Tetraspanin CD81 and Their Effect on Cancer Cell Migration. | Biomolecules | 2023 | https://conductscience.org/library/papers/36979448 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| CDKN2A | 1029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| IDO1 | 3620 | PubTator's text mining | https://conductscience.org/library/genes/3620 | NCBI Gene |
| PTEN | 5728 | PubTator's text mining | https://conductscience.org/library/genes/5728 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36009010
GET https://conductscience.org/api/papers/v1/36009010/references?page=2